Table 4. Changes in renal function between the patient groups during follow-up.
| Variables | Fixation type | p | |
| Suprarenal (n=114) | Infrarenal (n=54) | ||
| Mean±SD | Mean±SD | ||
| Creatinine (mg/dL) | |||
| Baseline | 0.8±0.5 | 0.8±0.3 | 0 330 |
| Follow-up | 1.3±0.9 | 1.1±0.5 | 0 175 |
| Change in creatinine level | 0.5±0.7 | 0.3±0.4 | 0 168 |
| eGFR using MDRD- (mL/min/1.73 m2) | |||
| Baseline | 113.4±62.4 | 108.7±36.9 | 0 607 |
| Follow-up | 78.5±42.6 | 76.9±3.0 | 0 804 |
| Change in MDRD | 38.5±48.5 | 32.7±297 | 0 420 |
| Ccr using Crockcroft-Gault (mL/min) | |||
| Baseline | 84.3±44.3 | 78.6±35.4 | 0 414 |
| Follow-up | 61.6±32.2 | 58. 2±28.7 | 0 505 |
| Change in Ccr (mg/dL) | 25.4±29.0 | 20. 9±19 8 | 0. 310 |
| eGFR using CKD-EPI (mL/min/1.73 m2) | |||
| Baseline | 83.8±23.4 | 85. 5±17. 8 | 0 639 |
| Follow-up | 65.9±27.6 | 69 3±24. 5 | 0.437 |
| Change in eGFR* | 191±18.8 | 17 2±17 5 | 0.541 |
| Mean follow-up (month) | 44.7±37.1 | 38 0±31 8 | 0.256 |
| SD: Standard deviation; eGFR: Estimated glomerular filtration rate; MDRD: Modification of Diet in Renal Disease; Ccr: Creatinine clearance rate; CKD-EPI: Chronic Kidney Disease-Epidemiology Collaboration. | |||